(Q40505899)

English

Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Rabies human diploid cell vaccine elicits cross-neutralising and cross-protecting immune responses against European and Australian bat lyssaviruses (English)

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

0 references

author name string

Brookes SM

1

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Parsons G

2

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Johnson N

3

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

McElhinney LM

4

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Fooks AR

5

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

language of work or name

0 references

publication date

1 July 2005

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

23

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

32

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

4101-4109

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Evidence of two Lyssavirus phylogroups with distinct pathogenicity and immunogenicity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

Novel lyssaviruses isolated from bats in Russia

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

New lyssavirus genotype from the Lesser Mouse-eared Bat (Myotis blythi), Kyrghyzstan

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

Rabies and other lyssavirus diseases

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

Antigenic variants of rabies virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

Avirulent mutants of rabies virus and their use as live vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

Effect of strain differences on the potency testing of rabies vaccines in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

Effects of vaccine route and dosage on protection from rabies after intracerebral challenge in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

Effect of heterogeneity of rabies virus strain and challenge route on efficacy of inactivated rabies vaccines in mice

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

Comparative study of two human diploid rabies vaccines administered with antirabies globulin

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

T and B cell human responses to European bat lyssavirus after post-exposure rabies vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

Development of a fluorescent antibody virus neutralisation test (FAVN test) for the quantitation of rabies-neutralising antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

Phylogenetic comparison of the genus Lyssavirus using distal coding sequences of the glycoprotein and nucleoprotein genes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

Rabies immunosome (subunit vaccine) structure and immunogenicity. Pre- and post-exposure protection studies

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

In vitro evidence of cell-mediated immunity after exposure of mice to both live and inactivated rabies virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

The antigen-specific cell-mediated immune response in mice is suppressed by infection with pathogenic lyssaviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

Rabies virus-specific human T cell clones provide help for an in vitro antibody response against neutralizing antibody-inducing determinants of the viral glycoprotein

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

Antigenic variation in rabies and rabies-related viruses: cross-protection independent of glycoprotein-mediated virus-neutralizing antibody

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

Efficacy of rabies vaccines against Duvenhage virus isolated from European house bats (Eptesicus serotinus), classic rabies and rabies-related viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

Immunity against the European bat rabies (Duvenhage) virus induced by rabies vaccines: an experimental study in mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

European bat lyssavirus in Scottish bats

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

Experimental utility of rabies virus-neutralizing human monoclonal antibodies in post-exposure prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

Rabies subunit vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

The protective role of humoral neutralizing antibody in the NIH potency test for rabies vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

Characteristics of 11 rabies virus isolates in mice: titers and relative invasiveness of virus, incubation period of infection, and survival of mice with sequelae

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

Characterization of an antigenic determinant of the glycoprotein that correlates with pathogenicity of rabies virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

Molecular diversity of the Lyssavirus genus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

Heminested PCR assay for detection of six genotypes of rabies and rabies-related viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

based on heuristic

inferred from DOI database lookup

Chimeric lyssavirus glycoproteins with increased immunological potential

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2005.03.037

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2005.03.037

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

21 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40505899&oldid=1899448629"